Systemic immune-inflammation index as a predictor of venous thromboembolism in NSCLC patients treated with ICIs: a retrospective study
Open Access
- 23 April 2026
- journal article
- research article
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 26 (1)
Abstract
Venous thromboembolism (VTE) is a serious complication in non-small cell lung cancer (NSCLC), potentially exacerbated by immune checkpoint inhibitors (ICIsKeywords
Funding Information
- Medical and Health Guidance Project of Xiamen Science and Technology Bureau (3502Z20244ZD1115)
This publication has 30 references indexed in Scilit:
- External validation of the Khorana score for the prediction of venous thromboembolism in cancer patients: A systematic review and meta-analysisInternational Journal of Nursing Studies, 2024
- Models for predicting venous thromboembolism in ambulatory patients with lung cancer: A systematic review and meta-analysisThrombosis Research, 2024
- Venous thromboembolism risk in cancer patients receiving first‐line immune checkpoint inhibitor versus chemotherapyAmerican Journal of Hematology, 2023
- Venous thromboembolism in cancer patients: ESMO Clinical Practice GuidelineAnnals of Oncology, 2023
- Cancer-Associated Thrombosis: Implications toward Health-Related Quality of LifeSeminars in Thrombosis and Hemostasis, 2022
- Mechanisms and risk factors of thrombosis in cancerCritical Reviews in Oncology/Hematology, 2017
- Individualized Venous Thromboembolism Risk Stratification Using the 2005 Caprini Score to Identify the Benefits and Harms of Chemoprophylaxis in Surgical PatientsAnnals of Surgery, 2017
- Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung CancerNew England Journal of Medicine, 2016
- Incidence of venous thromboembolism in patients with cancer – A cohort study using linked United Kingdom databasesEuropean Journal of Cancer, 2013
- Incidence and predictors of venous thromboembolism (VTE) among ambulatory high‐risk cancer patients undergoing chemotherapy in the United StatesCancer, 2012